Chinese Traditional and Herbal Drugs
|
2025, 56(22): 8447-8457
Potential pathways of traditional Chinese medicines in intervening diabetic kidney disease: Modulation of non-coding RNAs
Full
WANG Wenru1, WANG Xinhui1, LI Jixin2, CHEN Yao1, YANG Jiayi1, ZHAN Tian1, LIANG Ying1, YU Renhuan1
Affiliations
1 Department of Nephrology, Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing 100091, China;
2 Department of Cardiovascular, Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing 100091, China
doi: 10.7501/j.issn.0253-2670.2025.22.033
Outline
Diabetic kidney disease (DKD) is a common microvascular complication of diabetes mellitus, and its pathogenesis is complex and involves multiple pathological processes. In recent years, much attention has been paid to the regulatory role of non-coding RNAs (ncRNAs) in the development of DKD, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs, which are involved in the progression of DKD by affecting gene expression, signaling pathways and cellular functions. It was found that astragalus polysaccharide could promote autophagy and alleviate DKD by targeting lncRNA Gm41268/prolactin receptor, and Coptidis Rhizoma could inhibit the epithelial-mesenchymal transition and fibrogenesis of DKD through lncRNA CLYBL-AS2-miR-204-5p-SNAI1 axis. Traditional Chinese medicines (TCMs), with their multi-targeted, multi-pathway action characteristics, by regulating ncRNAs in the DKD prevention and treatment showed unique advantages. This review summarized the potential molecular mechanisms of TCMs in regulating DKD through interfering with the ncRNA network, aiming to provide new ideas for the targeted treatment of DKD and highlighting the application prospects of TCM in the field of epigenetic regulation. Future studies need to further combine high-throughput sequencing and bioinformatics technologies to explore the TCM-ncRNA-target gene interaction network in depth, in order to promote the modernization of Chinese medicines and the development of precision therapy.
traditional Chinese medicine
/
active ingredient
/
diabetic kidney disease
/
non-coding RNA
/
epigenetic
王文茹, 王新慧, 李纪新, 陈瑶, 杨嘉仪, 詹添, 梁莹, 余仁欢.
中药干预糖尿病肾脏疾病的潜在途径:调控非编码RNA.
中草药,
2025
, 56
(22)
: 8447
-8457
.
DOI: 10.7501/j.issn.0253-2670.2025.22.033
WANG Wenru, WANG Xinhui, LI Jixin, CHEN Yao, YANG Jiayi, ZHAN Tian, LIANG Ying, YU Renhuan.
Potential pathways of traditional Chinese medicines in intervening diabetic kidney disease: Modulation of non-coding RNAs[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(22)
: 8447
-8457
.
DOI: 10.7501/j.issn.0253-2670.2025.22.033
Year 2025 volume 56 Issue 22
50
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.22.033
- Receive Date:2025-09-14
- Online Date:2026-11-13